-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Idexx Laboratories Inc /De quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2024.
- Idexx Laboratories Inc /De Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$2.57M, a 31.6% increase year-over-year.
- Idexx Laboratories Inc /De annual Deferred Income Tax Expense (Benefit) for 2023 was -$48.3M, a 38.5% decline from 2022.
- Idexx Laboratories Inc /De annual Deferred Income Tax Expense (Benefit) for 2022 was -$34.9M, a 915% decline from 2021.
- Idexx Laboratories Inc /De annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.44M, a 90.6% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)